Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
William J. Newell
|
| gptkbp:collaboratesWith |
gptkb:EMD_Serono
gptkb:Merck gptkb:Bristol_Myers_Squibb |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
oncology
antibody-drug conjugates immuno-oncology therapeutics |
| gptkbp:foundedYear |
2003
|
| gptkbp:founder |
William J. Boyle
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sutro Biopharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
STRO-001
STRO-002 |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
STRO
|
| gptkbp:technology |
cell-free protein synthesis
|
| gptkbp:website |
https://www.sutrobio.com/
|
| gptkbp:bfsParent |
gptkb:South_San_Francisco,_California,_USA
|
| gptkbp:bfsLayer |
7
|